Camptosar®, Campto®, Irinotecan, is is the commercial name of Oxaliplatin, a chemotherapy drug.
- CamptosarCamptosar®, Campto®, Irinotecan, is a chemotherapy, intravenous infusion, indicated for the treatment of patients with with: Metastatic colorectal cancer: 1. In combination with 5-fluorouracil and folinic acid in patients without prior chemotherapy for metastatic disease. 2. As a single agent in patients who have failed an established 5-fluorouracil containing treatment regimen. For the treatment of patients with small cell lung cancer, SCLC. For the treatment of patients with gastric cancer. Irinotecan in combination with leucovorin, oxaliplatin and 5-fluorouracil for the first-line treatment of patients with metastatic pancreatic adenocarcinoma